Metsera
Phase 3Breakthroughs that change patients’ lives.
Founded
2023
Focus
AntibodiesBiologicsRNA & Gene Therapy
About
Breakthroughs that change patients’ lives.
Funding History
2Total raised: $340M
Series A$290MARCH Venture PartnersJan 15, 2024
Seed$50MARCH Venture PartnersMay 15, 2023
Company Info
TypePrivate
Founded2023
LocationCambridge, United States
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile